Actively Recruiting
Neuroprotective Effect of Remote Ischemic Post-conditioning in Out-of-hospital Cardiac Arrest
Led by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · Updated on 2026-04-13
48
Participants Needed
1
Research Sites
115 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Lead Sponsor
F
French Society for Intensive Care
Collaborating Sponsor
AI-Summary
What this Trial Is About
Patients admitted to intensive care unit (ICU) following an out-of-hospital cardiac arrest (OHCA) have a high morbidity and mortality rate, primarily due to ischemia-reperfusion (I/R) syndrome leading to anoxic-ischemic brain injury. Despite current recommended advanced life support therapies, no specific treatment or procedure has yet been shown to improve the neurological outcome of such patients. Remote ischemic post-conditioning (RIPOST) which usually consists of applying brief and repeated cycles of ischemia alternating with reperfusion by inflating and deflating a blood pressure cuff or a pneumatic tourniquet placed around a limb, is a promising strategy to protect organs against I/R injury, including brain. Regarding cardiac arrest, pre-clinical studies have demonstrated an improvement in neurological outcome in animal subjects treated with RIPOST after cardiopulmonary resuscitation. The aim of our study is to demonstrate the benefit of early RIPOST in OHCA patients in reducing neurological injury and organ failure related to I/R syndrome.
CONDITIONS
Official Title
Neuroprotective Effect of Remote Ischemic Post-conditioning in Out-of-hospital Cardiac Arrest
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Out-of-hospital cardiac arrest with stable return of spontaneous circulation longer than 20 minutes
- Patient receiving invasive mechanical ventilation for coma with Glasgow score less than 8
- Availability of a lower limb without intravenous infusion or blood pressure cuff
- Randomization and first session of intervention within 4 hours after return of spontaneous circulation
- Consent obtained from next-of-kin or inclusion under emergency procedure
You will not qualify if you...
- Age under 18 years or pregnancy
- Unable to walk without assistance or bedridden with severe disability (mRS of 4 or 5)
- Interval between cardiac arrest and return of spontaneous circulation over 60 minutes
- Unwitnessed cardiac arrest with asystole as first rhythm
- Cardiac arrest occurring in hospital
- Refractory cardiac arrest with no stable return of spontaneous circulation
- Cardiac arrest from trauma, hemorrhage, stroke, or hanging
- Persistent low mean arterial pressure below 65 mmHg despite treatment
- Active uncontrolled bleeding
- Contraindication to use of pneumatic tourniquet on both lower limbs
- Use of extracorporeal arteriovenous circulation before inclusion
- Previous inclusion in this study
- Participation in another interventional study
- Under judicial protection measures
- Lack of French social security coverage
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier Intercommunal Toulon-La Seyne sur Mer
Toulon, Var, France, 83100
Actively Recruiting
Research Team
C
Chelly Jonathan, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here